HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microparticle-containing oncotic solutions augment in-vitro clot disruption by ultrasound.

Abstract
Echocardiographic contrast agents enhance blood clot disruption by ultrasound. It has been suggested that the microbubbles add nuclei for the enhancement of cavitation by ultrasound. However, microbubbles are rapidly destroyed by the ultrasound energy. We assessed whether non-gas filled colloidal solutions (hyperoncotic medium molecular hydroxyethyl starch and degraded gelatin polypeptides) will facilitate clot disruption by ultrasound. In two separate experiments human blood clots, 200-400 mg in weight, were weighed and then immersed for 15 seconds in 10 ml normal saline solution containing 0%, 0.1%, 1%, 2%, and 5% of hyperoncotic medium molecular hydroxyethyl starch or 0%, 0.035%, 0.175%, 0.35%, and 0.7% degraded gelatin polypeptides. Clots were randomized to 10 seconds 20 kHz ultrasound or immersion without ultrasound. After treatment, the clots were reweighed, and the percent difference in weight was calculated. Non-gas filled microparticle-containing solutions such as hyperoncotic medium molecular hydroxyethyl starch and degraded gelatin polypeptides significantly augmented blood clot disruption by ultrasound. The effect is dependent on the colloidal solution concentration with maximal effect achieved with 1% hyperoncotic medium molecular hydroxyethyl starch and 0.35% degraded gelatin polypeptides.
AuthorsY Birnbaum, Z Iakobishvili, A Porter, D Hasdai, S Atar, R J Siegel, A Battler
JournalThrombosis research (Thromb Res) Vol. 98 Issue 6 Pg. 549-57 (Jun 15 2000) ISSN: 0049-3848 [Print] United States
PMID10899354 (Publication Type: Journal Article)
Chemical References
  • Colloids
  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Polygeline
Topics
  • Blood Coagulation (drug effects)
  • Colloids (therapeutic use)
  • Humans
  • Hydroxyethyl Starch Derivatives (therapeutic use)
  • Plasma Substitutes (pharmacology, therapeutic use)
  • Polygeline (pharmacology, therapeutic use)
  • Thrombolytic Therapy (methods)
  • Thrombosis (therapy)
  • Ultrasonic Therapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: